ClinicalTrialsFinder

Limited-stage Small Cell Lung Cancer (LS-SCLC) Clinical Trials in Beijing, Beijing Municipality

1 recruitingBeijing, Beijing Municipality, China

Showing 1–1 of 1 trials

Recruiting

Prediction of Response to PD-L1 Inhibitor After Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer Using Multi-omics-based Liquid Biopsy

Limited-stage Small Cell Lung Cancer (LS-SCLC)
Peking University Cancer Hospital & Institute65 enrolled1 locationNCT06869239